The Valley Desk

NCT02743078 · Interventional trial

Optune® Plus Bevacizumab in Bevacizumab-Refractory Recurrent Glioblastoma

Overall registry status Terminated

Phase 2

Conditions Glioblastoma, Glioma, Gliosarcoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov